IL17A and neoplasm: Furthermore, treatment with extracellular vesicles significantly enhanced the expression levels of crucial molecules in the IL-17A pathway, IL-17A, TRAF6 and c-FOS in tumor tissue and suppressed immune responses of CD8+ cells in vivo [167].